Your shopping cart is empty!
We offer private label services around our full range of reagent manufacturing capabilities performed by highly trained professionals. Use our expertise to produce custom buffers, reagents and solutions, including sterile solutions, in multiple size formats.
A top biotechnology company with an established portfolio of life science equipment and some consumables was faced with the challenge of expanding its supporting consumables for their equipment line. As the company is set up more for equipment production, they did not want to divert resources to the production of consumables.
As a leading manufacturer of consumables, we were able to offer this OEM partner a modified version of one of our products as their product in multiple formats, including all the custom packaging and label requirements.
Following a rigorous audit by this leading biotechnology company, we were selected as their OEM partner to private label supporting consumables for their equipment. This long-term OEM partner has continued to expand the OEM portfolio with us.
A top biotechnology company with an extensive portfolio of reagents and protein extraction tools faced repeated enquiries for large volumes of a sterile lysis reagent in specialized 10ml vials. Although the company has the capabilities to manufacture the product the volume and time placed unwanted restrictions on their production capacity.
Working closely with this OEM partner, we developed a standard operating procedure (SOP) with several QC check points to ensure the product matched their quality specifications and employed our capabilities of sterile, bulk manufacturing and product filling.
Following an in-depth review of our ISO9001: 2008 (now a ISO9001:2015 certified company) quality management system and the product SOP by this biotechnology company, we were selected as their OEM partner to private label this sterile lysis reagent and fill a gap in their portfolio.
A diagnostic company specializing in novel platforms with applications in oncology and diagnostics developed an automated cell retrieval system to enrich intact and viable Circulating Tumour Cells (CTCs) from small amounts of blood. They used a proprietary buffer of ours in the development of the platform and required private labeling to offer the buffer with the platform to maintain the integrity of the process.
With established procedures for converting our products to private label, we were readily able to meet this diagnostic companies request.
On further discussion with the diagnostic company and a review of our SOP we were able to modify the production and offer this as an in-vitro diagnostics (IVD) product that fit with their platform.